Novo Nordisk

Novo Nordisk is a global healthcare company with a rich history and a strong commitment to improving the lives of people with chronic diseases. Founded in 1923, the company has grown to become a leader in diabetes care, producing innovative insulin products and devices that help millions manage their condition effectively.

In addition to diabetes, Novo Nordisk is also dedicated to treating other serious chronic conditions such as obesity, haemophilia, and growth disorders. The company invests heavily in research and development, striving to bring new therapies to market that can make a significant difference in patients’ lives.

Core Values and Vision

At the heart of Novo Nordisk’s operations are its core values: innovation, quality, and responsibility. These principles guide the company’s efforts to create sustainable solutions for healthcare challenges worldwide.

• Innovation: Continuously seeking new ways to improve treatment options.
• Quality: Ensuring the highest standards in product development and manufacturing.
• Responsibility: Committed to ethical practices and corporate social responsibility.

Novo Nordisk operates in more than 80 countries and markets its products in over 170 countries, making it a truly global player in the pharmaceutical industry. The company’s headquarters are located in Bagsværd, Denmark, but it has a significant presence in the UK, where it collaborates with healthcare professionals and institutions to enhance patient care.

With a workforce of approximately 45,000 employees worldwide, Novo Nordisk fosters a culture of inclusivity and teamwork, empowering its staff to contribute to the company’s mission of driving change in healthcare.

As a pioneer in diabetes care, Novo Nordisk remains focused on addressing the growing global health challenge posed by diabetes and related conditions, ensuring that patients have access to the best possible treatments and support.